日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19

新冠疫情期间,癌症临床试验中采用分散式试验要素支持FDA批准

Patel, Timil H; Corneli, Amy; Balcazar, Pamela; Lipset, Craig; Calvert, Sara B; Mervin-Blake, Sabrena; Nalawade, Vinit; Kluetz, Paul G

FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma

FDA批准摘要:Tremelimumab联合Durvalumab用于治疗不可切除的肝细胞癌患者

Patel, Timil H; Brewer, Jamie R; Fan, Jiaxin; Cheng, Joyce; Shen, Yuan-Li; Xiang, Yue; Zhao, Hong; Lemery, Steven J; Pazdur, Richard; Kluetz, Paul G; Fashoyin-Aje, Lola A

FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement

FDA批准摘要:Pemigatinib用于治疗既往接受过治疗、无法切除的局部晚期或转移性胆管癌,伴有FGFR2融合或其他重排

Patel, Timil H; Marcus, Leigh; Horiba, M Naomi; Donoghue, Martha; Chatterjee, Somak; Mishra-Kalyani, Pallavi S; Schuck, Robert N; Li, Yangbing; Zhang, Xinyuan; Fourie Zirkelbach, Jeanne; Charlab, Rosane; Liu, Jiang; Yang, Yuching; Lemery, Steven J; Pazdur, Richard; Theoret, Marc R; Fashoyin-Aje, Lola A

Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality

申办方对 COVID-19 疫情对介入性癌症临床试验方案和数据质量影响的看法

Unger, Joseph M; Stires, Hillary; Levit, Laura A; Stewart, Mark; McKelvey, Brittany Avin; Canin, Beverly; Dressler, Emily; Flaherty, Keith; Fredette, Peter; Jones, Lee; McCann, Peggy; Miller, Therica; Onitilo, Adedayo A; Palmieri, Fran; Patel, Timil; Paul, Rocio; Smith, Gary L; Bruinooge, Suanna S; Garrett-Mayer, Elizabeth; Lei, Xiudong Jennifer; Alva, Ajjai; Schenkel, Caroline

Silico-tuberculosis amidst COVID-19 pandemic: global scenario and Indian perspective

新冠疫情下的硅结核病:全球形势及印度视角

Roy, Priyanka; Bardhan, Mainak; Roy, Shubhajeet; Singh, Utkarsh; Suresh, Timil; Anand, Ayush

Monitoring Macro- and Microcirculation in the Critically Ill: A Narrative Review

危重患者宏观和微循环监测:叙述性综述

Muzaffar, Syed Nabeel; Pradhan, Akshyaya; Siddiqui, Suhail Sarwar; Roy, Shubhajeet; Suresh, Timil

Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI

索拉非尼治疗晚期肝细胞癌生存期的可靠预测:MRI 上 1D 和 3D 定量肿瘤反应标准的比较

Doemel, Luzie A; Chapiro, Julius; Laage Gaupp, Fabian; Savic, Lynn Jeanette; Kucukkaya, Ahmet S; Petukhova, Alexandra; Tefera, Jonathan; Zeevi, Tal; Lin, MingDe; Schlachter, Todd; Jaffe, Ariel; Strazzabosco, Mario; Patel, Timil; Stein, Stacey M

Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases

肥大细胞白血病合并血液肿瘤的综合临床病理及分子分析:5例病例报告及深入研究

Li, Philippa; Biancon, Giulia; Patel, Timil; Pan, Zenggang; Kothari, Shalin; Halene, Stephanie; Prebet, Thomas; Xu, Mina L

Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis

局部胰腺癌患者接受多药联合化疗(伴或不伴放疗)后,切缘阴性切除和病理降期:一项基于国家癌症数据库的分析

Miccio, Joseph A; Talcott, Wesley J; Patel, Timil; Park, Henry S; Cecchini, Michael; Salem, Ronald R; Khan, Sajid A; Stein, Stacey; Kortmansky, Jeremy S; Lacy, Jill; Narang, Amol; Herman, Joseph; Jabbour, Salma K; Hallemeier, Christopher L; Johung, Kimberly; Jethwa, Krishan R

Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System

耶鲁斯米洛医院系统转移性胰腺癌一线FOLFIRINOX方案与吉西他滨联合白蛋白紫杉醇方案的临床结果

Patel, Timil; Miccio, Joseph; Cecchini, Michael; Srikumar, Thejal; Stein, Stacey; Kortmanksy, Jeremy; Johung, Kimberly; Lacy, Jill